1. Home
  2. FJET vs XOMA Comparison

FJET vs XOMA Comparison

Compare FJET & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FJET

Starfighters Space Inc. Common Stock

N/A

Current Price

$6.42

Market Cap

275.1M

ML Signal

N/A

Logo XOMA Corporation

XOMA

XOMA Corporation

N/A

Current Price

$29.09

Market Cap

308.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FJET
XOMA
Founded
2022
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.1M
308.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FJET
XOMA
Price
$6.42
$29.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$60.60
AVG Volume (30 Days)
983.7K
102.7K
Earning Date
04-30-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.95
Revenue Next Year
N/A
$6.20
P/E Ratio
N/A
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$4.51
$18.40
52 Week High
$28.56
$39.92

Technical Indicators

Market Signals
Indicator
FJET
XOMA
Relative Strength Index (RSI) 40.34 63.57
Support Level $5.94 $29.07
Resistance Level $8.46 $35.17
Average True Range (ATR) 0.86 1.52
MACD 0.03 0.31
Stochastic Oscillator 5.87 73.97

Price Performance

Historical Comparison
FJET
XOMA

About FJET Starfighters Space Inc. Common Stock

Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida. The company operates supersonic aircraft capable of sustained Mach 2 flight and configured to carry payloads to high altitudes for air launch to space. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company provides commercial space services and related aerospace capabilities.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: